Full Text
The Full Text of this article is available as a PDF (290.7 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Abenhaim L., Moride Y., Brenot F., Rich S., Benichou J., Kurz X., Higenbottam T., Oakley C., Wouters E., Aubier M. Appetite-suppressant drugs and the risk of primary pulmonary hypertension. International Primary Pulmonary Hypertension Study Group. N Engl J Med. 1996 Aug 29;335(9):609–616. doi: 10.1056/NEJM199608293350901. [DOI] [PubMed] [Google Scholar]
- Brent R. L. Bendectin: review of the medical literature of a comprehensively studied human nonteratogen and the most prevalent tortogen-litigen. Reprod Toxicol. 1995 Jul-Aug;9(4):337–349. doi: 10.1016/0890-6238(95)00020-b. [DOI] [PubMed] [Google Scholar]
- Connolly H. M., Crary J. L., McGoon M. D., Hensrud D. D., Edwards B. S., Edwards W. D., Schaff H. V. Valvular heart disease associated with fenfluramine-phentermine. N Engl J Med. 1997 Aug 28;337(9):581–588. doi: 10.1056/NEJM199708283370901. [DOI] [PubMed] [Google Scholar]
- Pellikka P. A., Tajik A. J., Khandheria B. K., Seward J. B., Callahan J. A., Pitot H. C., Kvols L. K. Carcinoid heart disease. Clinical and echocardiographic spectrum in 74 patients. Circulation. 1993 Apr;87(4):1188–1196. doi: 10.1161/01.cir.87.4.1188. [DOI] [PubMed] [Google Scholar]